December 7, 2023
U.S. Digital Therapeutics Market

U.S. Digital Therapeutics Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Chronic Diseases And Growing Adoption Of Digital Health Solutions

Market Overview:

Digital therapeutics is a subset of digital health that utilizes technology to offer evidence-based therapeutic interventions for the prevention, management, and treatment of various medical conditions. These interventions are typically delivered through smartphone or web-based applications and are clinically validated to provide effective results. They have the potential to improve patient outcomes, reduce healthcare costs, and enhance overall patient experience. Digital therapeutics can be used in the management of chronic conditions such as diabetes, cardiovascular diseases, respiratory diseases, and mental health disorders, among others.

Market Dynamics:

The U.S. digital therapeutics market is primarily driven by the increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, and the growing need for effective and convenient treatment options. The rising adoption of digital health solutions, technological advancements in mobile and wireless devices, and the growing awareness about the benefits of digital therapeutics among patients and healthcare professionals are also contributing to market growth. Furthermore, the favorable reimbursement policies for digital therapeutics and the increasing investments by key market players are expected to further propel market growth in the coming years. However, regulatory challenges and data privacy concerns may hinder market growth to some extent.

The global U.S. Digital Therapeutics Market Demand is estimated to be valued at US$ 2.11 billion in 2023 and is expected to exhibit a CAGR of 33.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis:

The U.S. digital therapeutics market can be segmented based on application, end user, and sales channel. The application segment can be further divided into preventive and treatment applications. The treatment application segment dominates the market due to the increasing prevalence of chronic diseases and the rising demand for cost-effective treatment options. The preventive application segment is also witnessing significant growth as more individuals are becoming proactive about managing their health and preventing diseases.

PEST Analysis:

Political: The political landscape in the U.S. is favorable for the digital therapeutics market, with the government supporting innovative healthcare solutions and investments in technology-driven healthcare.

Economic: The growing healthcare expenditure and increasing insurance coverage in the U.S. are contributing to the growth of the digital therapeutics market. The market is also benefiting from the rising adoption of telemedicine and remote patient monitoring technologies.

Social: The U.S. population is becoming more health-conscious and digital-savvy, leading to the increased acceptance and adoption of digital therapeutics. The demand for personalized healthcare solutions and self-management tools is also driving market growth.

Technological: Rapid advancements in technology, such as artificial intelligence, machine learning, and wearable devices, are fueling the growth of the digital therapeutics market in the U.S. These technological developments have enabled the development of innovative and effective digital therapeutic solutions.

Key Takeaways:

The U.S. digital therapeutics market is expected to witness high growth, exhibiting a CAGR of 33.8% over the forecast period of 2023-2030. This growth can be attributed to the increasing prevalence of chronic diseases, the demand for cost-effective treatment options, and the rising adoption of telemedicine and remote patient monitoring technologies.

In terms of regional analysis, the U.S. is the fastest-growing and dominating region in the digital therapeutics market. The country has a well-established healthcare infrastructure, favorable reimbursement policies, and a supportive regulatory framework, which are driving market growth.

Key players operating in the U.S. digital therapeutics market include 2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc., Teladoc Health, Lark Technologies, Kaia Health, Fitbit, Cognoa Inc., and Akili Interactive Labs. These companies are focusing on strategic partnerships, product launches, and research and development activities to gain a competitive edge in the market.


  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it